Amarantus Bioscience Holdings Inc (AMBS)

[Rotten Johnny]

MANF in International Development Phases

January 6th, 2014 at 11:30 am

http://www.thechairmansblog.com/company_post/unlocking-shareholder-value-milestones-approach-uplisting-2014/#sthash.QIpIh73m.dpuf";

"The next major milestones for LymPro are the completion of the Analytical Performance Package and the 1st Clinical Performance data. A significant opportunity exists for LymPro development in national and international jurisdictions following these key sets of data.

We intend to enter correspondence with US and international healthcare regulatory bodies in the 1st half of 2014 regarding our MANF program. Management believes there are significant opportunities for MANF development in Asia, as well as the US and Europe."